Atherosclerosis: pathogenesis and key cellular processes, current and emerging therapies, key challenges, and future research directions

YH Chan, DP Ramji - Atherosclerosis: Methods and Protocols, 2022 - Springer
Atherosclerosis is the principal cause of cardiovascular disease that continues to be a
substantial drain on healthcare systems, being responsible for about 31% of all global …

[HTML][HTML] Macrophages and foam cells: Brief overview of their role, linkage, and targeting potential in atherosclerosis

AV Poznyak, NG Nikiforov, AV Starodubova… - Biomedicines, 2021 - mdpi.com
Atherosclerosis is still one of the main causes of death around the globe. This condition
leads to various life-threatening cardiovascular complications. However, no effective …

The pathogenesis of atherosclerosis

G Douglas, KM Channon - Medicine, 2014 - Elsevier
Atherosclerosis is a chronic, inflammatory disease of the arterial wall that underlies many of
the common causes of cardiovascular morbidity and mortality, including myocardial …

Mechanisms of disease: macrophage-derived foam cells emerging as therapeutic targets in atherosclerosis

RP Choudhury, JM Lee, DR Greaves - Nature clinical practice …, 2005 - nature.com
The limited efficacy of current treatment strategies for targeting atherosclerosis and its
complications requires new therapeutic options to be explored. From early fatty-streak …

Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities

M Bäck, A Yurdagul Jr, I Tabas, K Öörni… - Nature Reviews …, 2019 - nature.com
Atherosclerosis is a lipid-driven inflammatory disease of the arterial intima in which the
balance of pro-inflammatory and inflammation-resolving mechanisms dictates the final …

Lipid-laden foam cells in the pathology of atherosclerosis: shedding light on new therapeutic targets

CL Galindo, S Khan, X Zhang, YS Yeh… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction Lipid-laden foam cells within atherosclerotic plaques are key players in all
phases of lesion development including its progression, necrotic core formation, fibrous cap …

Novel strategies to target inflammatory processes in atherosclerosis

T Imanishi, T Akasaka - Current pharmaceutical design, 2013 - ingentaconnect.com
Atherosclerosis is characterized by chronic inflammation of the vascular wall. Macrophages,
which differentiate from circulating monocytes, give rise to foam cells by excessive …

Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy

JE McLaren, DR Michael, TG Ashlin, DP Ramji - Progress in lipid research, 2011 - Elsevier
Cardiovascular disease is the biggest killer globally and the principal contributing factor to
the pathology is atherosclerosis; a chronic, inflammatory disorder characterized by lipid and …

The different facets of dyslipidemia and hypertension in atherosclerosis

J Hurtubise, K McLellan, K Durr, O Onasanya… - Current atherosclerosis …, 2016 - Springer
Atherosclerosis is the narrowing of arteries due to the accumulation of macrophages
overloaded with lipids resulting in foam cell formation, and these events occur preferentially …

Monocyte fate in atherosclerosis

I Hilgendorf, FK Swirski, CS Robbins - … , thrombosis, and vascular …, 2015 - Am Heart Assoc
Monocytes and their descendant macrophages are essential to the development and
exacerbation of atherosclerosis, a lipid-driven inflammatory disease. Lipid-laden …